Early Gastric Cancer with Lymph Node Metastasis

Narumiya, Kosuke; Oguma, Hidetoshi

doi:10.1097/sla.0b013e318211d91b

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the depth of infiltration in the pT1a carcinomas larger than 1 cm, the metastatic risk is below 5% in pT1a‐m1/m2 carcinomas and increases up to 13% for pT1a‐m3 cases . In pT1b tumors, the rate of lymphatic metastasis ranges from 15 to 20% in pT1b‐sm1‐ to 24–40% in pT1b‐sm3 carcinomas .…”

Section: Metastatic Behavior Of Egcmentioning

confidence: 97%

“…The overall survival time is 5–84 months , in EGCs with metastases in distant lymph nodes, 4‐ to 49 months (median 6 months) in associated bone metastases , and 21 weeks for brain metastases . Patients with solitary bone metastases present a relatively higher survival than those with multicentric bone metastases (6.2 ± 1.2 vs 2.9 ± 0.5 months) .…”

Section: Egc and Survival Ratementioning

confidence: 99%

See 1 more Smart Citation

Aberrant metastatic behavior and particular features of early gastric cancer

Gurzu

Jung

Kádár

2015

APMIS

View full text Add to dashboard Cite

In this paper, we have focused on the metastatic behavior of EGC and its particularities. The main factors that are currently considered as predictors of the metastatic behavior and that are used in the therapeutic decision (endoscopic resection vs surgical removal) are the tumor size (upper or bellow 2 cm), depth of infiltration, angiolymphatic invasion, the presence or absence of ulceration, and histologic type (undifferentiated vs differentiated carcinomas). However, most of the metastatic cases were published as case reports or case series. This is the reason why a proper estimation of metastatic risk in EGC is not well known. To date, 79 cases presenting bone metastases, three reports of brain metastases, and one EGC that was associated with skin metastasis were published. However, occult metastasis, lymph node micrometastasis, and skip metastasis can also occur and should be identified. Making a synthesis of the literature data that is correlated with our experience, we finally proposed the inclusion of the six Japanese subgrouping system, tumor size, angiolymphatic invasion, and micrometastasis as components of the pTNM staging system, which should be particularly adapted for EGC.

show abstract

Section: Metastatic Behavior Of Egcmentioning

confidence: 97%